148 related articles for article (PubMed ID: 35381590)
1. Exosomal miR-4639 and miR-210 in Plasma and Urine as Biomarkers in IgA Nephropathy.
Zhao S; Sun Y; Mao Q; Zhou C; Chen Y; Xue D
Nephron; 2022; 146(6):539-552. PubMed ID: 35381590
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of urinary exosomal microRNAs in IgA nephropathy.
Min QH; Chen XM; Zou YQ; Zhang J; Li J; Wang Y; Li SQ; Gao QF; Sun F; Liu J; Xu YM; Lin J; Huang LF; Huang B; Wang XZ
J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28383146
[TBL] [Abstract][Full Text] [Related]
3. Urinary Exosomes and Exosomal CCL2 mRNA as Biomarkers of Active Histologic Injury in IgA Nephropathy.
Feng Y; Lv LL; Wu WJ; Li ZL; Chen J; Ni HF; Zhou LT; Tang TT; Wang FM; Wang B; Chen PS; Crowley SD; Liu BC
Am J Pathol; 2018 Nov; 188(11):2542-2552. PubMed ID: 30142333
[TBL] [Abstract][Full Text] [Related]
4. Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy.
Liang S; Cai GY; Duan ZY; Liu SW; Wu J; Lv Y; Hou K; Li ZX; Zhang XG; Chen XM
BMC Nephrol; 2017 Feb; 18(1):63. PubMed ID: 28201996
[TBL] [Abstract][Full Text] [Related]
5. Urinary Exosomal MicroRNAs as New Noninvasive Biomarkers of IgA Nephropathy.
Li S; Hao H; Li R; Guo S
Tohoku J Exp Med; 2022 Mar; 256(3):215-223. PubMed ID: 35314529
[TBL] [Abstract][Full Text] [Related]
6. Urinary exosomal miRNA-451a can be used as a potential noninvasive biomarker for diagnosis, reflecting tubulointerstitial damage and therapeutic response in IgA nephropathy.
Zhang Q; Zhao Y; Luo Y; Guo S; Hou H; Han X; Zhou Y
Ren Fail; 2024 Dec; 46(1):2319326. PubMed ID: 38379319
[TBL] [Abstract][Full Text] [Related]
7. Urinary exosomal miRNA signature of IgA nephropathy: a case-control study.
Shankar M; Shetty A; N S M; C G S; A K; Tennankore K
Sci Rep; 2023 Dec; 13(1):21400. PubMed ID: 38049447
[TBL] [Abstract][Full Text] [Related]
8. Clinical and pathological correlation between urinary exosome miR-223 and IgAN patients.
Song J; Qin X; Li H; Huang G; Bi H
Clin Nephrol; 2023 Nov; 100(5):209-215. PubMed ID: 37622669
[TBL] [Abstract][Full Text] [Related]
9. Urinary miR-16-5p can be used as a potential marker of endocapillary hypercellularity in IgA nephropathy.
Zhang M; Duan ZY; Zhang QY; Xu XG; Zhang Y; Wang P; Duan SW; Wu J; Chen XM; Cai GY
Sci Rep; 2023 Apr; 13(1):6048. PubMed ID: 37055445
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of urinary exosomal microRNAs in patients with IgA nephropathy.
Yoon SY; Kim JS; Jung SW; Kim YG; Hwang HS; Moon JY; Lee SH; Seo JW; Seok J; Tae D; Jeong K
Sci Rep; 2023 Oct; 13(1):17201. PubMed ID: 37821628
[TBL] [Abstract][Full Text] [Related]
11. Urinary exosomal circular RNAs of sex chromosome origin are associated with gender-related risk differences of clinicopathological features in patients with IgA nephropathy.
Luan R; Tian G; Zhang H; Shi X; Li J; Zhang R; Lu X
J Nephrol; 2022 May; 35(4):1069-1078. PubMed ID: 34292531
[TBL] [Abstract][Full Text] [Related]
12. Non-Proximal Renal Tubule-Derived Urinary Exosomal miR-200b as a Biomarker of Renal Fibrosis.
Yu Y; Bai F; Qin N; Liu W; Sun Q; Zhou Y; Yang J
Nephron; 2018; 139(3):269-282. PubMed ID: 29539618
[TBL] [Abstract][Full Text] [Related]
13. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.
Dong J; Peng T; Gao J; Jia X; Yan G; Wang Y
BMC Immunol; 2018 Jun; 19(1):18. PubMed ID: 29925312
[TBL] [Abstract][Full Text] [Related]
14. Circulating MiR-29a, Possible Use as a Biomarker for Monitoring IgA Nephropathy.
Hu H; Wan Q; Li T; Qi D; Dong X; Xu Y; Chen H; Liu H; Huang H; Wei C; Zhou W; Jiang S; Mo Z; Liao F; Xu Q; He Y
Iran J Kidney Dis; 2020 Mar; 14(2):107-118. PubMed ID: 32165595
[TBL] [Abstract][Full Text] [Related]
15. Urinary miRNA profile for the diagnosis of IgA nephropathy.
Szeto CC; Wang G; Ng JK; Kwan BC; Mac-Moune Lai F; Chow KM; Luk CC; Lai KB; Li PK
BMC Nephrol; 2019 Mar; 20(1):77. PubMed ID: 30832601
[TBL] [Abstract][Full Text] [Related]
16. A Pilot Study to Predict Risk of IgA Nephropathy Progression Based on miR-204 Expression.
Pawluczyk I; Nicholson M; Barbour S; Er L; Selvaskandan H; Bhachu JS; Barratt J
Kidney Int Rep; 2021 Aug; 6(8):2179-2188. PubMed ID: 34386667
[TBL] [Abstract][Full Text] [Related]
17. Urinary sediment microRNAs can be used as potential noninvasive biomarkers for diagnosis, reflecting the severity and prognosis of diabetic nephropathy.
Han Q; Zhang Y; Jiao T; Li Q; Ding X; Zhang D; Cai G; Zhu H
Nutr Diabetes; 2021 Jun; 11(1):24. PubMed ID: 34193814
[TBL] [Abstract][Full Text] [Related]
18. Profiling and initial validation of urinary microRNAs as biomarkers in IgA nephropathy.
Wang N; Bu R; Duan Z; Zhang X; Chen P; Li Z; Wu J; Cai G; Chen X
PeerJ; 2015; 3():e990. PubMed ID: 26056621
[TBL] [Abstract][Full Text] [Related]
19. High serum IgA/C3 ratio better predicts a diagnosis of IgA nephropathy among primary glomerular nephropathy patients with proteinuria ≤ 1 g/d: an observational cross-sectional study.
Gong WY; Liu M; Luo D; Liu FN; Yin LH; Li YQ; Zhang J; Peng H
BMC Nephrol; 2019 Apr; 20(1):150. PubMed ID: 31039758
[TBL] [Abstract][Full Text] [Related]
20. Serum miR-192 Is Related to Tubulointerstitial Lesion and Short-Term Disease Progression in IgA Nephropathy.
Fan Q; Lu R; Zhu M; Yan Y; Guo X; Qian Y; Zhang L; Dai H; Ni Z; Gu L
Nephron; 2019; 142(3):195-207. PubMed ID: 30808829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
